CMS Proposes Rescinding Rule Tying Medicare Drug Prices to International Benchmarks
- August 13, 2021
The Centers for Medicare & Medicaid Services proposed August 10 (86 Fed. Reg. 43618) to withdraw a controversial Trump-era interim final rule to align certain Medicare drug reimbursement with international prices.
ARTICLE TAGS
You must be logged in to access this content.